Mycophenolate mofetil (MMF) reduces the pool of dividing and activated CD4+ T cells, contributing to control virus load. Impact on VIRUS LOAD and CD4+ T cell counts of a unique supervised treatment interruption coupled with MMF is assessed in a non-randomized controlled study.
Long term control of HIV-1 RNA Replication following a Unique Supervized Treatment Interruption and Mycophenolate Mofetil Therapy in patients treated with HAART since Primary HIV-1 Infection / Rizzardi, G. P.; Guaraldi, Giovanni; Lazzarin, A.; Pantaleo, G.; Tambussi, G.. - STAMPA. - not applicable:(2004), pp. 210 (n. 400)-210. (Intervento presentato al convegno 11th Conference on Retroviruses and Opportunistic Infections tenutosi a Moscon West san Francisco, CA, USA nel Febbraio 8-11, 2004).
Long term control of HIV-1 RNA Replication following a Unique Supervized Treatment Interruption and Mycophenolate Mofetil Therapy in patients treated with HAART since Primary HIV-1 Infection
GUARALDI, Giovanni;
2004
Abstract
Mycophenolate mofetil (MMF) reduces the pool of dividing and activated CD4+ T cells, contributing to control virus load. Impact on VIRUS LOAD and CD4+ T cell counts of a unique supervised treatment interruption coupled with MMF is assessed in a non-randomized controlled study.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris